Filing Details

Accession Number:
0001209191-19-013268
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-25 20:00:24
Reporting Period:
2019-02-21
Accepted Time:
2019-02-25 20:00:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876378 Transenterix Inc. TRXC Surgical & Medical Instruments & Apparatus (3841) 112962080
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246530 P Joseph Slattery C/O Transenterix, Inc.
635 Davis Drive, Suite 300
Morrisville NC 27560
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-21 17,650 $3.25 44,929 No 4 S Direct
Common Stock Acquisiton 2019-02-22 26,292 $1.39 71,221 No 4 M Direct
Common Stock Disposition 2019-02-22 71,221 $3.25 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-02-22 26,292 $0.00 26,292 $1.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
774,708 2028-02-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,000 Indirect By IRA
Footnotes
  1. The transactions occurred pursuant to a written trading plan dated November 29, 2017, meeting the requirements of Rule 10b5-1(c) with these sales hitting an established sales price trigger of $3.25 per share.
  2. Following the sales on February 21, 2019 and February 22, 2019, the reporting person continues to beneficially own 25,000 shares of the company's common stock. The reporting person also holds stock options to acquire 2,448,178 shares of common stock, of which approximately 31% are vested, and restricted stock units representing an additional 931,999 shares of common stock subject to forfeiture restrictions.
  3. Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the reporting person's Employment Agreement with the Company.